From Wikipedia, the free encyclopedia
Jump to: navigation, search
JSC Pharmstandard
Type Public (OAO)
Traded as MCXPHST
Industry Pharmaceuticals
Founded 2003
Headquarters Dolgoprudny, Russia
Key people Viktor Vladimirovich Kharitonin,(Chairman)
Igor Konstantinovich Krylov, (CEO)
Products Remedies
Revenue Increase US$ 1.6 billion (2012)
Profit Increase US$ 321.1 million (2012)
Employees 5,001

Pharmstandard is the leading Russian pharmaceutical company, its headquartered in Dolgoprudny.

Pharmstandard portfolio includes over 200 products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc. Over 90 products offered by Pharmstandard are included in the List of Vital Pharmaceutical Products.[1]

The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.